MeritValue

Guardian Pharmacy Services, Inc.

GRDNdata completeness 88%2 fiscal years on file
The thesis, from the filings

Guardian Pharmacy Services, Inc. earns about -2% on invested capital. The cash-flow models don't apply cleanly here — the ledger says why below. Whether it’s worth owning at today’s price is the last question — and yours to answer, below.

i. The business — what you’d actually own
FigureFY 2024FY 2025
Revenue$1.23B1$1.45B1
Net income−$110M2$49.2M2
Operating cash flow$58M3$100.3M3
Capital expenditure$14.7M4$13.4M4
Free cash flow (derived)$43.3M3,4$86.8M3,4
Total debt$05$05
Cash & equivalents$4.66M6$65.6M6
Diluted shares——

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom). A derived or summed figure cites every filing line it was built from.

iii. Is this a good business?
Moat signal · return on invested capital
-2% avg · 2y
FY24 -36%FY25 32%

It earned an average -2% on invested capital over 2 years. Compare that to what it costs to fund the business.

seeing a moat in the numbers →
Management signal · capital allocation
— shares · 2y

Not enough history to read capital allocation.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.6.0
DCF · Growth Exit 10Y
not applicable
only 2 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 2 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
only 2 years of net income (need ≥3)
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Beyond this page

This page is free, and so is every other company on MeritValue.

In your AI assistant

Connect the MeritValue MCP server to Claude or another MCP client, ask about Guardian Pharmacy Services, Inc., and get these exact figures with their filing receipts — not an improvised DCF.

Get a free key →
Screen by model

Pull the companies with a published value under any model (up to 500 a request, filtered by data completeness) into your own sheet or agent. Screening is what Analyst adds, at $9/month.

See pricing →
On iPhone

Follow GRDN and keep your own price beside the value. The same engine, with the same receipts.

MeritValue on the App Store →
Sources — the receipts
  1. 10-K filed 2026-03-11 · periods ending 2024-12-31, 2025-12-31 · accession 0001193125-26-102172 (Revenues)
  2. 10-K filed 2026-03-11 · periods ending 2024-12-31, 2025-12-31 · accession 0001193125-26-102172 (NetIncomeLoss)
  3. 10-K filed 2026-03-11 · periods ending 2024-12-31, 2025-12-31 · accession 0001193125-26-102172 (NetCashProvidedByUsedInOperatingActivities)
  4. 10-K filed 2026-03-11 · periods ending 2024-12-31, 2025-12-31 · accession 0001193125-26-102172 (PaymentsToAcquireProductiveAssets)
  5. 10-K filed 2026-03-11 · periods ending 2024-12-31, 2025-12-31 · accession 0001193125-26-102172 (LongTermDebt)
  6. 10-K filed 2026-03-11 · periods ending 2024-12-31, 2025-12-31 · accession 0001193125-26-102172 (CashAndCashEquivalentsAtCarryingValue)